These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22319003)

  • 81. Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells.
    Chin CC; Chen CN; Kuo HC; Shi CS; Hsieh MC; Kuo YH; Tung SY; Lee KF; Huang WS
    J Cell Physiol; 2015 Jul; 230(7):1430-7. PubMed ID: 25201147
    [TBL] [Abstract][Full Text] [Related]  

  • 82. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.
    Ignacio RM; Kabir SM; Lee ES; Adunyah SE; Son DS
    PLoS One; 2016; 11(10):e0164189. PubMed ID: 27723802
    [TBL] [Abstract][Full Text] [Related]  

  • 83. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.
    Legendre F; Dudhia J; Pujol JP; Bogdanowicz P
    J Biol Chem; 2003 Jan; 278(5):2903-12. PubMed ID: 12419823
    [TBL] [Abstract][Full Text] [Related]  

  • 84. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

  • 85. IL-4 Modulates CCL11 and CCL20 Productions from IL-1β-Stimulated Human Periodontal Ligament Cells.
    Hosokawa Y; Hosokawa I; Shindo S; Ozaki K; Matsuo T
    Cell Physiol Biochem; 2016; 38(1):153-9. PubMed ID: 26765337
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
    Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
    Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
    Legendre F; Bogdanowicz P; Boumediene K; Pujol JP
    J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis.
    Shirane J; Nakayama T; Nagakubo D; Izawa D; Hieshima K; Shimomura Y; Yoshie O
    Curr Eye Res; 2004 May; 28(5):297-306. PubMed ID: 15287366
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Epigenetically associated CCL20 upregulation correlates with esophageal cancer progression and immune disorder.
    Nan H; Zhou L; Liang W; Meng J; Lin K; Li M; Hou J; Wang L
    Pathol Res Pract; 2021 Dec; 228():153683. PubMed ID: 34798484
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Influence of Simulated Deep Brain Stimulation on the Expression of Inflammatory Mediators by Human Central Nervous System Cells In Vitro.
    Kubelt C; Molkewehrum H; Lucius R; Synowitz M; Held-Feindt J; Helmers AK
    Neuromolecular Med; 2022 Jun; 24(2):169-182. PubMed ID: 34216357
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Correction: Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35710298
    [No Abstract]   [Full Text] [Related]  

  • 92. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells.
    Kang Z; Wang C; Zepp J; Wu L; Sun K; Zhao J; Chandrasekharan U; DiCorleto PE; Trapp BD; Ransohoff RM; Li X
    Nat Neurosci; 2013 Oct; 16(10):1401-8. PubMed ID: 23995070
    [TBL] [Abstract][Full Text] [Related]  

  • 93. TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.
    Xiao Y; Jin J; Chang M; Nakaya M; Hu H; Zou Q; Zhou X; Brittain GC; Cheng X; Sun SC
    J Exp Med; 2014 Jul; 211(8):1689-702. PubMed ID: 24980047
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CCR6 (CC Chemokine Receptor 6) Is Essential for the Migration of Detrimental Natural Interleukin-17-Producing γδ T Cells in Stroke.
    Arunachalam P; Ludewig P; Melich P; Arumugam TV; Gerloff C; Prinz I; Magnus T; Gelderblom M
    Stroke; 2017 Jul; 48(7):1957-1965. PubMed ID: 28611085
    [TBL] [Abstract][Full Text] [Related]  

  • 95. IL-17 in Chronic Inflammation: From Discovery to Targeting.
    Beringer A; Noack M; Miossec P
    Trends Mol Med; 2016 Mar; 22(3):230-241. PubMed ID: 26837266
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate.
    Pavelka K; Chon Y; Newmark R; Lin SL; Baumgartner S; Erondu N
    J Rheumatol; 2015 Jun; 42(6):912-9. PubMed ID: 25877498
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The role of IL-17 in CNS diseases.
    Waisman A; Hauptmann J; Regen T
    Acta Neuropathol; 2015 May; 129(5):625-37. PubMed ID: 25716179
    [TBL] [Abstract][Full Text] [Related]  

  • 98. An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression.
    Luo Q; Liu Y; Shi K; Shen X; Yang Y; Liang X; Lu L; Qiao W; Chen A; Hong D; Sun Y; Xu Q
    Immunity; 2023 Sep; 56(9):2006-2020.e6. PubMed ID: 37473759
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis.
    Zhu Y; Wu Z; Yan W; Shao F; Ke B; Jiang X; Gao J; Guo W; Lai Y; Ma H; Chen D; Xu Q; Sun Y
    EMBO Mol Med; 2022 Mar; 14(3):e14455. PubMed ID: 34936223
    [TBL] [Abstract][Full Text] [Related]  

  • 100. RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis.
    Zelic M; Pontarelli F; Woodworth L; Zhu C; Mahan A; Ren Y; LaMorte M; Gruber R; Keane A; Loring P; Guo L; Xia TH; Zhang B; Orning P; Lien E; Degterev A; Hammond T; Ofengeim D
    Cell Rep; 2021 May; 35(6):109112. PubMed ID: 33979622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.